The article, “Current State of Immunotherapy” was authored by Richard W. Joseph, MD, and has been approved for 1 AMA PRA Category 1 credits.TM
After purchasing this CME Certification, you will receive a link to the article and the test in your email.
Faculty/Credentials: Richard W. Joseph, MD, Assistant Professor, Mayo Clinic Florida
1. Explain the mechanism of immunotherapy in cancer.
2. Describe the clinical utility of anti-CTLA4 agents.
3. Describe the clinical utility of anti-PD1 agents.
4. Describe the clinical utility of TVEC.
CME Credit Eligibility:
A minimum passing grade of 70% must be achieved. Only one re-take opportunity will be granted.
Richard W. Joseph, MD reports that he is a consultant for Merck, BMS, Genoptix and Eisai, and that he has received grant/research support from Merck, Roche, BMS, Amgen, and X4. Dr. Joseph also reports that his article will not include discussion of any investigational or unlabeled use of a product.
Disclosure of Conflicts of Interest:
St. Vincent’s Healthcare (SVHC) requires speakers, faculty, CME Committee and other individuals who are in a position to control the content of this educations activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly evaluated by SVHC for fair balance, scientific objectivity of studies mentioned in the presentation and educational materials used as basis for content, and appropriateness of patient care recommendations.
Joint Sponsorship Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of St. Vincent’s Healthcare and the Duval County Medical Society. St. Vincent’s Healthcare designates this educational activity for a maximum of 1 AMA PRA Category 1 credits. TM Physicians should only claim credit commensurate with the extent of their participation in the activity.